(CVGW) Calavo Growers - Overview
Sector: Consumer Defensive | Industry: Food Distribution | Exchange: NASDAQ (USA) | Market Cap: 473m USD | Total Return: 7.8% in 12m
Avg Turnover: 8.12M
Qual. Beats: 0
Rev. Trend: -69.3%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Calavo Growers, Inc. (CVGW) is a global leader in the sourcing, packaging, and distribution of fresh produce, specializing in avocados, tomatoes, and papayas. The company operates through two primary segments: Fresh, which focuses on raw agricultural commodities, and Prepared, which manufactures processed guacamole and avocado pulp for retail and foodservice channels.
The business model relies heavily on a vertically integrated supply chain and partnerships with growers in major production regions like Mexico and California. As part of the Packaged Foods & Meats sector, the company faces high sensitivity to commodity price fluctuations and seasonal crop yields, which directly impact procurement costs and margins. Calavo leverages a diverse portfolio of proprietary brands and trademarks to maintain market share across mass-merchandise, grocery, and wholesale sectors.
Investors looking for deeper financial metrics and valuation trends may find further insights by exploring ValueRay. Founded in 1924 and based in Santa Paula, California, the company remains a central player in the global avocado supply chain.
- Avocado harvest volume and pricing volatility impact core segment gross margins
- Strategic divestiture of fresh-cut business streamlines operations toward higher-margin avocado processing
- Fluctuating Mexican peso exchange rates influence cost of goods sold and profitability
- Consumer demand shifts for value-added guacamole products drive retail and foodservice revenue
- Supply chain logistics and freight costs dictate operating margins across international distribution channels
| Net Income: 16.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.04 > 1.0 |
| NWC/Revenue: 13.56% < 20% (prev 12.69%; Δ 0.86% < -1%) |
| CFO/TA 0.06 > 3% & CFO 17.3m > Net Income 16.1m |
| Net Debt (-25.3m) to EBITDA (26.5m): -0.96 < 3 |
| Current Ratio: 2.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.9m) vs 12m ago -0.04% < -2% |
| Gross Margin: 10.24% > 18% (prev 0.11%; Δ 1.01k% > 0.5%) |
| Asset Turnover: 206.4% > 50% (prev 230.3%; Δ -23.85% > 0%) |
| Interest Coverage Ratio: 25.80 > 6 (EBITDA TTM 26.5m / Interest Expense TTM 743k) |
| A: 0.28 (Total Current Assets 152.6m - Total Current Liabilities 69.1m) / Total Assets 298.2m |
| B: 0.08 (Retained Earnings 25.0m / Total Assets 298.2m) |
| C: 0.06 (EBIT TTM 19.2m / Avg Total Assets 298.6m) |
| D: 0.28 (Book Value of Equity 25.0m / Total Liabilities 90.8m) |
| Altman-Z'' = 2.83 = A |
| DSRI: 1.00 (Receivables 42.9m/48.0m, Revenue 616.3m/688.3m) |
| GMI: 1.03 (GM 10.24% / 10.57%) |
| AQI: 1.15 (AQ_t 0.27 / AQ_t-1 0.24) |
| SGI: 0.90 (Revenue 616.3m / 688.3m) |
| TATA: -0.00 (NI 16.1m - CFO 17.3m) / TA 298.2m) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of May 24, 2026, the stock is trading at USD 26.46 with a total of 310,542 shares traded.
Over the past week, the price has changed by -0.04%,
over one month by -4.38%,
over three months by +2.67% and
over the past year by +7.83%.
Calavo Growers has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy CVGW.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 27 | 2% |
P/E Forward = 18.6916
P/S = 0.7675
P/B = 2.3875
P/EG = 3.4354
Revenue TTM = 616.3m USD
EBIT TTM = 19.2m USD
EBITDA TTM = 26.5m USD
Long Term Debt = 17.9m USD (estimated: total debt 22.4m - short term 4.48m)
Short Term Debt = 4.48m USD (from shortTermDebt, last quarter)
Debt = 22.4m USD (from shortLongTermDebtTotal, last quarter) (leases 22.4m already included)
Net Debt = -25.3m USD (calculated: Debt 22.4m - CCE 47.7m)
Enterprise Value = 447.7m USD (472.9m + Debt 22.4m - CCE 47.7m)
Interest Coverage Ratio = 25.80 (Ebit TTM 19.2m / Interest Expense TTM 743k)
EV/FCF = 30.55x (Enterprise Value 447.7m / FCF TTM 14.7m)
FCF Yield = 3.27% (FCF TTM 14.7m / Enterprise Value 447.7m)
FCF Margin = 2.38% (FCF TTM 14.7m / Revenue TTM 616.3m)
Net Margin = 2.61% (Net Income TTM 16.1m / Revenue TTM 616.3m)
Gross Margin = 10.24% ((Revenue TTM 616.3m - Cost of Revenue TTM 553.1m) / Revenue TTM)
Gross Margin QoQ = 12.43% (prev 9.34%)
Tobins Q-Ratio = 1.50 (Enterprise Value 447.7m / Total Assets 298.2m)
Interest Expense / Debt = 3.32% (Interest Expense 743k / Debt 22.4m)
Taxrate = 37.04% (473k / 1.28m)
NOPAT = 12.1m (EBIT 19.2m * (1 - 37.04%))
Current Ratio = 2.21 (Total Current Assets 152.6m / Total Current Liabilities 69.1m)
Debt / Equity = 0.11 (Debt 22.4m / totalStockholderEquity, last quarter 205.7m)
Debt / EBITDA = -0.96 (Net Debt -25.3m / EBITDA 26.5m)
Debt / FCF = -1.72 (Net Debt -25.3m / FCF TTM 14.7m)
Total Stockholder Equity = 206.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.40% (Net Income 16.1m / Total Assets 298.2m)
RoE = 7.82% (Net Income TTM 16.1m / Total Stockholder Equity 206.0m)
RoCE = 8.56% (EBIT 19.2m / Capital Employed (Equity 206.0m + L.T.Debt 17.9m))
RoIC = 6.03% (NOPAT 12.1m / Invested Capital 200.2m)
WACC = 7.32% (E(472.9m)/V(495.3m) * Re(7.57%) + D(22.4m)/V(495.3m) * Rd(3.32%) * (1-Tc(0.37)))
Discount Rate = 7.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 46.67 | Cagr: 0.32%
[DCF] Terminal Value 73.10% ; FCFF base≈15.9m ; Y1≈14.0m ; Y5≈11.3m
[DCF] Fair Price = 11.54 (EV 180.9m - Net Debt -25.3m = Equity 206.2m / Shares 17.9m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.28 | # QB: 0
Revenue Correlation: -69.34 | Revenue CAGR: -6.32% | SUE: 0.40 | # QB: 0
EPS current Quarter (2026-07-31): EPS=0.47 | Chg30d=-10.38% | Revisions=+0% | Analysts=2
EPS current Year (2026-10-31): EPS=1.41 | Chg30d=-9.03% | Revisions=-33% | GrowthEPS=-13.0% | GrowthRev=-17.1%
EPS next Year (2027-10-31): EPS=1.52 | Chg30d=-5.00% | Revisions=-20% | GrowthEPS=+7.8% | GrowthRev=-3.1%
[Analyst] Revisions Ratio: -33%